Resource Type

Journal Article 4

Year

2021 1

2010 2

2008 1

Keywords

Chemosensitivity 1

Gemcitabine 1

Intrahepatic cholangiocarcinoma 1

Peripheral blood mononuclear cells 1

cholangiocarcinoma 1

growth 1

hilar cholangiocarcinoma 1

metastasis 1

morphology 1

primary sclerosing cholangitis 1

prognostic factors 1

serum carbohydrate antigen 19-9 1

open ︾

Search scope:

排序: Display mode:

Hilar cholangiocarcinoma: Pathology and tumor biology

Dong KUANG, Guo-Ping WANG,

Frontiers of Medicine 2010, Volume 4, Issue 4,   Pages 371-377 doi: 10.1007/s11684-010-0130-6

Abstract: Hilar cholangiocarcinoma, first described by Klatskin in 1965, is a relatively rare tumor arising fromThe histomorphological features of hilar cholangiocarcinoma are identical with other extra- and intra-hepaticThe most common disease associated with cholangiocarcinoma is primary sclerosing cholangitis.The development of cholangiocarcinoma is a multistep process associated with several mutations in oncogenesHilar cholangiocarcinoma is a slowly growing tumor and tends to spread longitudinally along the bile

Keywords: hilar cholangiocarcinoma     morphology     primary sclerosing cholangitis     metastasis     growth    

Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: A meta-analysis

Shang-Long LIU, Zi-Fang SONG, Qing-Gang HU, Shao-Bo HU, Jun LI, Qi-Chang ZHENG, Duo SHAN,

Frontiers of Medicine 2010, Volume 4, Issue 4,   Pages 457-462 doi: 10.1007/s11684-010-0240-1

Abstract: prognostic role of preoperative serum carbohydrate antigen (CA) 19-9 levels in the survival of patients with cholangiocarcinomaArticles published up to June 1, 2010 that evaluated preoperative CA19-9 levels and the prognosis of cholangiocarcinomaOne study dealt with extra-hepatic cholangiocarcinoma, while the other eight studies analyzed intra-hepaticcholangiocarcinoma.CA19-9 levels were associated significantly with the prognosis of patients with cholangiocarcinoma.

Keywords: cholangiocarcinoma     prognostic factors     serum carbohydrate antigen 19-9    

Diagnosis and treatment for advanced hilar cholangiocarcinoma: experience of 24 cases

ZHANG Zongming, ZHU Jianping, SU Yanming, GUO Jinxing, JIANG Nan, ZHANG Zichao, XING Hailin, LIU Kai, YUAN Haiming

Frontiers of Medicine 2008, Volume 2, Issue 2,   Pages 134-138 doi: 10.1007/s11684-008-0025-y

Abstract: The aim of this paper is to evaluate the efficacy of the surgical treatment for advanced hilar cholangiocarcinoma

Distinct Immune Signatures in Peripheral Blood Predict Chemosensitivity in Intrahepatic Cholangiocarcinoma Article

Tong Wu, Ying-Cheng Yang, Bo Zheng, Xue-Bing Shi, Wei Li, Wen-Cong Ma, Shan Wang, Zhi-Xuan Li, Yan-Jing Zhu, Jian-Min Wu, Kai-Ting Wang, Yan Zhao, Rui Wu, Cheng-Jun Sui, Si-Yun Shen, Xuan Wu, Lei Chen, Zhen-Gang Yuan, Hong-Yang Wang

Engineering 2021, Volume 7, Issue 10,   Pages 1381-1393 doi: 10.1016/j.eng.2021.01.014

Abstract: font-family:"Times New Roman",serif">Intrahepatic cholangiocarcinoma

Keywords: Intrahepatic cholangiocarcinoma     Gemcitabine     Chemosensitivity     Peripheral blood mononuclear cells    

Title Author Date Type Operation

Hilar cholangiocarcinoma: Pathology and tumor biology

Dong KUANG, Guo-Ping WANG,

Journal Article

Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: A meta-analysis

Shang-Long LIU, Zi-Fang SONG, Qing-Gang HU, Shao-Bo HU, Jun LI, Qi-Chang ZHENG, Duo SHAN,

Journal Article

Diagnosis and treatment for advanced hilar cholangiocarcinoma: experience of 24 cases

ZHANG Zongming, ZHU Jianping, SU Yanming, GUO Jinxing, JIANG Nan, ZHANG Zichao, XING Hailin, LIU Kai, YUAN Haiming

Journal Article

Distinct Immune Signatures in Peripheral Blood Predict Chemosensitivity in Intrahepatic Cholangiocarcinoma

Tong Wu, Ying-Cheng Yang, Bo Zheng, Xue-Bing Shi, Wei Li, Wen-Cong Ma, Shan Wang, Zhi-Xuan Li, Yan-Jing Zhu, Jian-Min Wu, Kai-Ting Wang, Yan Zhao, Rui Wu, Cheng-Jun Sui, Si-Yun Shen, Xuan Wu, Lei Chen, Zhen-Gang Yuan, Hong-Yang Wang

Journal Article